BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35714307)

  • 1. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
    Shin TH; Zhou Y; Chen S; Cordes S; Grice MZ; Fan X; Lee BC; Aljanahi AA; Hong SG; Vaughan KL; Mattison JA; Kohama SG; Fabre MA; Uchida N; Demirci S; Corat MAF; Métais JY; Calvo KR; Buscarlet M; Natanson H; McGraw KL; List AF; Busque L; Tisdale JF; Vassiliou GS; Yu KR; Dunbar CE
    Blood; 2022 Oct; 140(16):1774-1789. PubMed ID: 35714307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.
    Sano S; Oshima K; Wang Y; MacLauchlan S; Katanasaka Y; Sano M; Zuriaga MA; Yoshiyama M; Goukassian D; Cooper MA; Fuster JJ; Walsh K
    J Am Coll Cardiol; 2018 Feb; 71(8):875-886. PubMed ID: 29471939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis of Indeterminate Potential With Loss of
    Lin AE; Bapat AC; Xiao L; Niroula A; Ye J; Wong WJ; Agrawal M; Farady CJ; Boettcher A; Hergott CB; McConkey M; Flores-Bringas P; Shkolnik V; Bick AG; Milan D; Natarajan P; Libby P; Ellinor PT; Ebert BL
    Circulation; 2024 Apr; 149(18):1419-1434. PubMed ID: 38357791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in
    Yalcinkaya M; Liu W; Thomas LA; Olszewska M; Xiao T; Abramowicz S; Papapetrou EP; Westerterp M; Wang N; Tabas I; Tall AR
    Circulation; 2023 Nov; 148(22):1764-1777. PubMed ID: 37781816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TET2 mutation as prototypic clonal hematopoiesis lesion.
    Guarnera L; Jha BK
    Semin Hematol; 2024 Feb; 61(1):51-60. PubMed ID: 38431463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
    Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
    J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
    Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
    Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET2-mutant clonal hematopoiesis and risk of gout.
    Agrawal M; Niroula A; Cunin P; McConkey M; Shkolnik V; Kim PG; Wong WJ; Weeks LD; Lin AE; Miller PG; Gibson CJ; Sekar A; Schaefer IM; Neuberg D; Stone RM; Bick AG; Uddin MM; Griffin GK; Jaiswal S; Natarajan P; Nigrovic PA; Rao DA; Ebert BL
    Blood; 2022 Sep; 140(10):1094-1103. PubMed ID: 35714308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells.
    McClatchy J; Strogantsev R; Wolfe E; Lin HY; Mohammadhosseini M; Davis BA; Eden C; Goldman D; Fleming WH; Conley P; Wu G; Cimmino L; Mohammed H; Agarwal A
    Nat Commun; 2023 Dec; 14(1):8102. PubMed ID: 38062031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
    Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
    JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
    Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
    Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with clonal hematopoiesis and interaction with marrow environment.
    Nannya Y
    J Bone Miner Metab; 2023 May; 41(3):380-387. PubMed ID: 36346484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.
    Fuster JJ; MacLauchlan S; Zuriaga MA; Polackal MN; Ostriker AC; Chakraborty R; Wu CL; Sano S; Muralidharan S; Rius C; Vuong J; Jacob S; Muralidhar V; Robertson AA; Cooper MA; Andrés V; Hirschi KK; Martin KA; Walsh K
    Science; 2017 Feb; 355(6327):842-847. PubMed ID: 28104796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils.
    Huerga Encabo H; Aramburu IV; Garcia-Albornoz M; Piganeau M; Wood H; Song A; Ferrelli A; Sharma A; Minutti CM; Domart MC; Papazoglou D; Gurashi K; Llorian Sopena M; Goldstone R; Fallesen T; Wang Q; Ariza-McNaughton L; Wiseman DH; Batta K; Gupta R; Papayannopoulos V; Bonnet D
    Cell Stem Cell; 2023 Jun; 30(6):781-799.e9. PubMed ID: 37267914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal hematopoiesis and autoimmunity.
    Kishtagari A; Corty RW; Visconte V
    Semin Hematol; 2024 Feb; 61(1):3-8. PubMed ID: 38423847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal Hematopoiesis Before, During, and After Human Spaceflight.
    Mencia-Trinchant N; MacKay MJ; Chin C; Afshinnekoo E; Foox J; Meydan C; Butler D; Mozsary C; Vernice NA; Darby C; Schatz MC; Bailey SM; Melnick AM; Guzman ML; Bolton K; Braunstein LZ; Garrett-Bakelman F; Levine RL; Hassane DC; Mason CE
    Cell Rep; 2020 Dec; 33(10):108458. PubMed ID: 33242405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9.
    Christen F; Hablesreiter R; Hoyer K; Hennch C; Maluck-Böttcher A; Segler A; Madadi A; Frick M; Bullinger L; Briest F; Damm F
    Leukemia; 2022 Apr; 36(4):1102-1110. PubMed ID: 34782715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of IL-1β inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial.
    Woo J; Lu D; Lewandowski A; Xu H; Serrano P; Healey M; Yates DP; Beste MT; Libby P; Ridker PM; Steensma DP
    Blood Adv; 2023 Dec; 7(24):7471-7484. PubMed ID: 37934948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.